---
figid: PMC5497057__ncomms15921-f2
figtitle: Alternative splicing promotes tumour aggressiveness and drug resistance
  in African American prostate cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5497057
filename: ncomms15921-f2.jpg
figlink: /pmc/articles/PMC5497057/figure/f2/
number: F2
caption: DS events in AA PCa versus EA PCa were frequently detected in multiple oncogenic
  signalling pathways. Depicted pathway is a composite of PI3K/AKT/mTOR, RAS/RAF/MAPK,
  CDK/RB1, MDM2/TP53 and WNT/GSK3/CTNNB1/APC signalling. Open figures indicate oncogenes
  and closed figures indicate tumour suppressor genes. ‘DS’ indicates that a differential
  alternative splicing event was detected for a particular oncogene or tumour suppressor
  gene.
papertitle: Alternative splicing promotes tumour aggressiveness and drug resistance
  in African American prostate cancer.
reftext: Bi-Dar Wang, et al. Nat Commun. 2017;8:15921.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6557484
figid_alias: PMC5497057__F2
figtype: Figure
redirect_from: /figures/PMC5497057__F2
ndex: a61117af-df35-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5497057__ncomms15921-f2.html
  '@type': Dataset
  description: DS events in AA PCa versus EA PCa were frequently detected in multiple
    oncogenic signalling pathways. Depicted pathway is a composite of PI3K/AKT/mTOR,
    RAS/RAF/MAPK, CDK/RB1, MDM2/TP53 and WNT/GSK3/CTNNB1/APC signalling. Open figures
    indicate oncogenes and closed figures indicate tumour suppressor genes. ‘DS’ indicates
    that a differential alternative splicing event was detected for a particular oncogene
    or tumour suppressor gene.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - PDGFRA
  - NTRK1
  - NTRK2
  - NTRK3
  - EPHB1
  - EPHB2
  - EPHB3
  - EPHB4
  - EPHB6
  - EPHA1
  - EPHA2
  - EPHA3
  - EPHA4
  - EPHA5
  - EPHA6
  - EPHA7
  - EPHA8
  - EPHA10
  - TNFRSF1A
  - INSR
  - IGF1R
  - INSRR
  - RASGRP2
  - NF1
  - PTEN
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - GSK3A
  - GSK3B
  - MDM2
  - CDK6
  - CDK4
  - ATM
  - TSC2
  - TSC1
  - CCL26
  - CTNNB1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - RB1
  - RBM45
  - TP53
  - APC
  - PROC
  - MTOR
  - STK11
  - BAK1
  - GNAS
  - GNAL
  - Breast cancer
  - Cancer
  - Lung cancer
  - Melanoma
---
